This study will create a prospective registry of consecutive patients with Atrial Fibrillation (Afib) considered for cardioversion treatment to document up-to-date practice of in-hospital treatment, with a focus on the characterization of type of Afib, as well as on treatments applied (drugs, devices, interventions and their combinations), and associated complications within 60 days after enrollment.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Cardiovascular Disease History of Participants Presenting With Atrial Fibrillation at Baseline (Admission)
Timeframe: Baseline (time of admission)
Co-Morbidity in Participants Presenting With Atrial Fibrillation at Baseline (Admission)
Timeframe: Baseline (time of admission)
Clinical Type of Atrial Fibrillation at Baseline (Admission)
Timeframe: Baseline (time of admission)
Treatments Utilized for Participants for Atrial Fibrillation
Timeframe: At time of Treatment (up to 1 day from admission)
Percentage of Participants Who Had a Successful Electrical or Pharmacological Cardioversion
Timeframe: At time of treatment (up to 1 day from admission)
Complications Experienced by Participants Who Underwent a Cardioversion for Treatment of Atrial Fibrillation
Timeframe: up to 60 days from day of treatment (cardioversion)